Manhattan Scientifics, Inc. (MHTX)
Manhattan Scientifics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, up 400.00% on the session, giving a market capitalisation of $55,928. On trailing twelve-month figures it carries a trailing P/E of -0.05, a net margin of 0.0%. Its beta of 9.61 implies it has historically moved more than the broad market.
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.
Manhattan Scientifics, Inc. is most often compared with the following Healthcare names: